Dr. Dylan Zylla received his M.D. from the University of Minnesota in 2005.This was followed by a residency in Internal Medicine, also at the University of Minnesota.He served as Chief Resident during his last year of residency.During his residency he was also involved in research in the laboratory of Dr. Douglas Yee studying the role of insulin-like growth factor receptor and breast cancer metastasis.Dr. Zylla entered the fellowship program in Hematology, Oncology and Transplantation at the University of Minnesota in 2009.
Publications
Zylla DM, Bergenstal E, Merrill JD, Douglas SD, Mooney K, Guo CJ, Song L, Ho WZ.CCR5 expression and B-chemokine production during placental neonatal monocyte differentiation.Pediatric Research 2003; 53:853-858.
Presentations
Zylla D.Blood glucose as an early predictor of insulin independence after islet allotransplantation.Poster presented at American College of Physicians; Minneapolis, MN; November 2005.
Zylla D, Borke K, Keene H, Lambrecht T, Mustafa T, Stark K, Wood T and Mosser G. Venous thromboembolism prophylaxis: Pitfalls and progress in treating hospitalized medical patients. Poster presented at American College of Physicians; Minneapolis, MN; November 2007.
Zylla D, Slungaard A, Vercellotti GM. Killer cells: A natural way to cure relpased acute myelogneous leukemia. Poster presented at American College of Physicians; Minneapolis, MN; November 2006.
